Aspire Biopharma Holdings, Inc. (ASBP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 6.01 |
| Open | 6.03 |
| Day High | 6.2 |
| Day Low | 5.81 |
| 52-Week High | 35 |
| 52-Week Low | 0.11 |
| Volume | 36,010 |
| Average Volume | 13.56M |
| Market Cap | 688,771 |
| PE | -0.25 |
| EPS | -23.8 |
| Moving Average 50 Days | 4.94 |
| Moving Average 200 Days | 4.93 |
| Change | -0.04 |
An Interview with the CEO: How Aspire Biopharma is Disrupting a $100 Billion Market with Sublingual Innovation
Newsfile
Mar 11, 2025 12:00 PM GMT
SmallCaps Daily Dives Deep with CEO Kraig Higginson to Discuss Aspire's Mission to Enhance Efficacy and Reduce Side EffectsNew York, New York--(Newsfile Corp. - March 11, 2025) - Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) ("Aspire" or the "Compan